IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells

Estrogen receptor-, progesterone receptor- and HER2-negative breast cancers, also known as triple-negative breast cancers (TNBCs), have poor prognoses and are refractory to current therapeutic agents, including epidermal growth factor receptor (EGFR) inhibitors. Resistance to anti-EGFR therapeutic a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncotarget
Main Authors: Merrouche, Yacine, Fabre, Joseph, Cure, Herve, Garbar, Christian, Fuselier, Camille, Bastid, Jeremy, Antonicelli, Frank, Al-Daccak, Reem, Bensussan, Armand, Giustiniani, Jerome
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2016
Fag:
Research Paper
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5288192/
https://ncbi.nlm.nih.gov/pubmed/27462789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10804
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker